combination therapy

Rotstein C, Lynch JP 3rd, Zhanel GG. Hospital-acquired bacterial pneumonia (HABP) and ventilator- associated bacterial pneumonia (VABP) in Canada:treatment update and the role of newRead more

By sjmartinez • October 10, 2023

Garon EB, Spira AI, Goldberg SB, Chaft JE, Papadimitrakopoulou V, Cascone T, Antonia SJ, Brahmer JR, Camidge DR, Powderly JD, Wozniak AJ, Felip E, WuRead more

By sjmartinez • July 24, 2023

Masson R, Seivright J, Shih T, Bennett RG, Hogeling M, Shi VY, Hsiao JL. Trimethoprim/sulfamethoxazole and cephalexin combination therapy in hidradenitis suppurativa patients: A seriesRead more

By sjmartinez • June 19, 2023

Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in PD-(L)1-Monotherapy Pretreated, Advanced Non-Small Cell Lung Cancer: Results From a Phase 1b Clinical Trial

By sjmartinez • May 7, 2023

Wang X, Liu X, Hugo W, Si L, Shi H. Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments. Front Immunol. 2022Read more

By sjmartinez • November 18, 2022

Nel AE, Mei KC, Liao YP, Liu X. Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli withRead more

By sjmartinez • November 15, 2022